Whether you're in need of a wedding guest dress, garden party outfit, or an instant serotonin boost, it's worth taking a peek at Lilly Pulitzer's latest Lilly Reserve collection.

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and the risks. Click for my LLY stock update.

Eli Lilly & Co. agreed to buy Verve Therapeutics Inc., a US biotech that’s seeking to use gene editing to prevent clogged arteries, for as much as $1.3 billion.

FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France, February 1, 2018.

Eli Lilly (NYSE:LLY) has been in the spotlight recently with a 3.96% share price increase over the past month. The selection of RyboDyn Inc. to join Lilly Gateway Labs stands out among recent ...

Lilly is expected to post earnings of $5.56 per share for the current quarter, representing a year-over-year change of +41.8%. Over the last 30 days, the Zacks Consensus Estimate has changed +0.5%.

It's the remarkable true story of one woman's fight for equal pay that impacts us all! Oscar-nominated actress Patricia Clarkson joined us to talk about her starring role in the new movie "Lilly ...

Boston Globe via Getty Images Eli Lilly’s $1.3 billion acquisition of Verve Therapeutics represents a strategic move into cardiovascular genetic medicine.

Lilly has been busy this year acquiring the rights to medicines developed by small pharmaceutical start-ups. Most notably, it acquired Scorpion Therapeutics and its PI3Kα inhibitor program for $2 ...

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on meeting demand for the drug in the world's most populous country.

And amid all that, Eli Lilly continues to grow its revenue at a faster pace than any of its comparable peers. In the first quarter, the company's revenue jumped by 45% year over year to $12.7 billion.

In light of the recent options history for Eli Lilly, it's now appropriate to focus on the company itself. We aim to explore its current performance. Current Position of Eli Lilly Currently ...